Physicians Will Expand Range of Mobile Activities to Include Administrative and Patient Care Tasks

Manhattan ResearchPhysicians will significantly expand the range of activities they conduct on mobile devices by 2012, according to Manhattan Research's "Future of Physician Media" report. Currently physicians primarily use mobile devices to access clinical content and perform quick tasks. By 2012, though, physician smartphone adoption is expected to reach 81% penetration and about half of this group will use their devices for administrative functions, learning, and patient care.

"Handheld devices are becoming more and more useful to physicians, partly because of the boom in physician-oriented apps and portable content," said Monique Levy, Senior Director of Research and lead author of the report. "Healthcare marketers can't afford to miss leveraging this channel to influence sales."

"The Future of Physician Media" is based on the findings from Manhattan Research's Taking the Pulse® v9.0 study conducted in Q1 2009 among 1,900 U.S. physicians. The report discusses how physician use of social media, mobile technology, and on demand digital resources will evolve over the next two years and serves as a guide for healthcare marketers and publishers looking to leverage imminent digital opportunities. For an excerpt from the report and purchasing information, please visit www.manhattanresearch.com/future-of-physician-media.

Report Outline
Title: The Future of Physician Media

Topics Covered:
I. Mobile Outlook

  • Adoption of Smartphone/PDAs Through 2012
  • Characteristics of Smartphone/PDA Users and Non Smartphone/PDA Users
  • Smartphone OS/Manufacturer Outlook
  • Activities on Smartphones/PDA Outlook
  • Examples of Emerging Mobile Products and Services
  • Activities Physicians Prefer Doing on Mobile Devices

II. Social Media Outlook

  • User-Generated Content Outlook
  • Types of User-Generated Content
  • Example of Surgery Video on YouTube
  • Physician Social Network Outlook
  • Examples of Physician Social Networks
  • Physician Adoption of General Social Networks for Professional and Personal Purposes
  • Frequency of Use of Various Online Resources

III. On Demand Outlook

  • Share of Physicians Going Online Daily
  • Occasions When Physicians Access the Internet
  • Channel Adoption Across Professional Activities
  • Weekly Use of Online Resources 2008-2009

About Taking the Pulse® v9.0
Taking the Pulse® v9.0 is a market research and strategic advisory service focused on which technologies physicians have adopted, how they are currently using them, and how they plan to use them in the future. The study was conducted in Q1 2009 among a nationally representative sample of 1,900 practicing U.S. physicians. Broad physician market research can be segmented to provide insight to the technology adoption and integration trends for over twenty specialist groups. For additional product information, please visit www.manhattanresearch.com/ttp.

About Manhattan Research
Manhattan Research, a Decision Resources, Inc. company, is a leading market research and advisory services firm for global pharmaceutical and healthcare companies. For more information, visit www.manhattanresearch.com.

About Decision Resources, Inc.
Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.decisionresourcesinc.com.

Most Popular Now

AstraZeneca to acquire CinCor Pharma to strengthen…

AstraZeneca has entered into a definitive agreement to acquire CinCor Pharma, Inc. (CinCor), a US-based clinical-stage biopharmaceutical company, focused on developing no...

NextPoint Therapeutics announces $80 million Serie…

NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today that it raised $80 million in Series B financing co-l...

Time-restricted eating reshapes gene expression th…

Numerous studies have shown health benefits of time-restricted eating including increase in life span in laboratory studies, making practices like intermittent fasting a ...

Incurable liver disease may prove curable

Research led by Associate Professor Duc Dong, Ph.D., has shown for the first time that the effects of Alagille syndrome, an incurable genetic disorder that affects the li...

Scientists develop a cancer vaccine to simultaneou…

Scientists are harnessing a new way to turn cancer cells into potent, anti-cancer agents. In the latest work from the lab of Khalid Shah, MS, PhD, at Brigham and Women’s ...

Bayer to accelerate drug discovery with Google Clo…

Bayer AG and Google Cloud announced a collaboration to drive early drug discovery that will apply Google Cloud's Tensor Processing Units (TPUs), which are custom-develope...

COVID-19 vaccines, prior infection reduce transmis…

Vaccination and boosting, especially when recent, helped to limit the spread of COVID-19 in California prisons during the first Omicron wave, according to an analysis by ...

Study identifies potential new approach for treati…

Targeting iron metabolism in immune system cells may offer a new approach for treating systemic lupus erythematosus (SLE) - the most common form of the chronic autoimmune...

Nanotechnology may improve gene therapy for blindn…

Using nanotechnology that enabled mRNA-based COVID-19 vaccines, a new approach to gene therapy may improve how physicians treat inherited forms of blindness. A collabo...

Acquisition of Neogene Therapeutics completed

AstraZeneca has completed the acquisition of Neogene Therapeutics Inc. (Neogene), a global clinical-stage biotechnology company pioneering the discovery, development and ...

Modified CRISPR-based enzymes improve the prospect…

Many genetic diseases are caused by diverse mutations spread across an entire gene, and designing genome editing approaches for each patient’s mutation would be impractic...

Pfizer expands 'An Accord for a Healthier World' p…

Pfizer Inc. (NYSE: PFE) announced that it has significantly expanded its commitment to An Accord for a Healthier World to offer the full portfolio of medicines and vaccin...